Llwytho...
Die-hard survivors: heterogeneity in apoptotic thresholds may underlie chemoresistance
The unmatched efficacy of microtubule-targeting agents (MTAs) as chemotherapeutics was once assumed to originate from their impact on mitotic processes; however, this misconception is being eroded by amassing data that MTAs instead target interphase functions in patients’ tumors. What remains murky...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Expert Rev Anticancer Ther |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4457617/ https://ncbi.nlm.nih.gov/pubmed/25695344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2015.1016425 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|